Taiwan, China Updates the Categories and Items of Narcotics

Time: Sep 16, 2025
中国台湾
Chemical Management

On August 25, 2025, the Executive Yuan of Taiwan, China, announced the revision of parts of the Categories and Items of Narcotics in accordance with the provisions of the Narcotics Hazard Prevention Act. The revisions took effect on August 27, 2025.

This update primarily involves adjustments and additions to the items listed under Category 2, Category 3, and Category 4 narcotics. The specific changes are as follows:

Category 2 Narcotics

Unless otherwise specified, includes their isomers, esters, ethers, and salts.

Item

Change

226

Ethyl 1-(1-phenylethyl)-1H-imidazole-carboxylateincluding its isomers Etomidateimidazole-4-carboxylate

Revised the original English name for Etomidate and specified inclusion of its isomers

230

Butomidateincluding its isomers n-Butyliso-Butylsec-Butyltert-Butyl

Added

231

Trifluoroethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylateCF3-Etomidate(TF-Etomidate)

Added

232

Flutomidateincluding its isomers 2-Fluoro3-Fluoro4-Fluoro])

Added

Category 3 Narcotics

Unless otherwise specified, includes their isomers, esters, ethers, and salts.

Item

Change

355

 

Methyl2-(1-butylindazole-3-carbonyl)amino-3,3-dimethylbutanoateMDMB-BINACA(MDMB-BUTINACA)

Added

356

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamideADB-4en-PINACA

Added

Category 4 Narcotics

Includes narcotic precursor chemicals. Unless otherwise specified, includes their isomers, esters, ethers, and salts.

Item

Change

58

Narcotic Precursor: tert-Butyl 4-oxopiperidine-1-carboxylateN-Boc-4-piperidone

Added

     

According to the Narcotics Hazard Prevention Act, narcotic drugs refer to narcotics and their products, as well as psychotropic substances and their products, which possess addictive potential, potential for abuse, and societal harm. The manufacture, transportation, or sale of such substances is punishable by criminal penalties or fines under the law.

Narcotics are categorized into four levels based on their degree of addictiveness, potential for abuse, and societal harm:

  • Category 1: Heroin, Morphine, Opium, Cocaine, and their analogous products.
  • Category 2: Poppy, Coca, Cannabis, Amphetamine, Pethidine, Pentazocine, and their analogous products.
  • Category 3: Secobarbital, Amobarbital, Nalorphine, and their analogous products.
  • Category 4: Allobarbital, Alprazolam, and their analogous products.

The categories and items of narcotics are regularly reviewed every three months by a review committee convened by the Ministry of Justice and the Ministry of Health and Welfare of the Taiwan region of China. The committee deliberates on narcotics, psychotropic substances, their products, and substances with similar chemical structures that exhibit addictive potential, potential for abuse, and societal harm. Approved changes are announced by the Executive Yuan and submitted to the Legislative Yuan for reference. The management of narcotics and psychotropic substances for medical and scientific use is regulated under relevant laws.

 

Further Information

Gazette

Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
icon-server
Hot Services
message
in